These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24830399)

  • 1. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis.
    Afghani E; Akshintala VS; Khashab MA; Law JK; Hutfless SM; Kim KJ; Lennon AM; Kalloo AN; Singh VK
    Endoscopy; 2014 Jul; 46(7):573-80. PubMed ID: 24830399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis.
    Mazaki T; Masuda H; Takayama T
    Endoscopy; 2010 Oct; 42(10):842-53. PubMed ID: 20886403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
    Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Efficacy of 3- or 5-cm Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Prospective, Randomized Trial.
    Fujisawa T; Kagawa K; Ochiai K; Hisatomi K; Kubota K; Sato H; Nakajima A; Matsuhashi N
    J Clin Gastroenterol; 2016 Mar; 50(3):e30-4. PubMed ID: 26280707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review.
    Choudhary A; Bechtold ML; Arif M; Szary NM; Puli SR; Othman MO; Pais WP; Antillon MR; Roy PK
    Gastrointest Endosc; 2011 Feb; 73(2):275-82. PubMed ID: 21295641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?
    Iqbal S; Shah S; Dhar V; Stavropoulos SN; Stevens PD
    Dig Dis Sci; 2011 Jan; 56(1):260-5. PubMed ID: 20464492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Chahal P; Tarnasky PR; Petersen BT; Topazian MD; Levy MJ; Gostout CJ; Baron TH
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):834-9. PubMed ID: 19447196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ
    World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
    Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials.
    Kochar B; Akshintala VS; Afghani E; Elmunzer BJ; Kim KJ; Lennon AM; Khashab MA; Kalloo AN; Singh VK
    Gastrointest Endosc; 2015 Jan; 81(1):143-149.e9. PubMed ID: 25088919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-Fr pancreatic plastic stents placed with common-type guidewires: Results from a prospective multinational registry.
    Sahar N; Ross A; Lakhtakia S; Coté GA; Neuhaus H; Bruno MJ; Haluszka O; Kozarek R; Ramchandani M; Beyna T; Poley JW; Maranki J; Freeman M; Kedia P; Tarnasky P;
    Dig Endosc; 2019 May; 31(3):299-306. PubMed ID: 30506606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis.
    Dubravcsik Z; Hritz I; Keczer B; Novák P; Lovász BD; Madácsy L
    Pancreatology; 2021 Jun; 21(4):704-713. PubMed ID: 33926821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial.
    Conigliaro R; Manta R; Bertani H; Manno M; Barbera C; Caruso A; Olivetti G; Melotti G; Frazzoni M
    Surg Endosc; 2013 Feb; 27(2):569-74. PubMed ID: 22926890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
    Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.
    Pahk A; Rigaux J; Poreddy V; Smith J; Al-Kawas F
    Dig Dis Sci; 2011 Oct; 56(10):3058-64. PubMed ID: 21487771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis.
    Mazaki T; Mado K; Masuda H; Shiono M
    J Gastroenterol; 2014 Feb; 49(2):343-55. PubMed ID: 23612857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.